Vanda Pharmaceuticals

Yahoo Finance • 7 days ago

Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight

The Charcot–Marie–Tooth disease market is poised for steady growth, driven by increasing disease awareness and improved diagnostic capabilities. Advancements in genetic testing are enabling earlier and more accurate diagnosis, expanding th... Full story

Yahoo Finance • 18 days ago

Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?

AnaptysBio, Inc. (NASDAQ:ANAB) is one of the best performing healthcare stocks so far in 2026. Piper Sandler cut the price target on AnaptysBio, Inc. (NASDAQ:ANAB) to $93 from $95 on May 4, reaffirming an Overweight rating on the shares. T... Full story

Yahoo Finance • 22 days ago

Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook

Earnings Call Insights: Vanda Pharmaceuticals (VNDA) Q1 2026 MANAGEMENT VIEW * "Vanda delivered strong commercial execution in the first quarter, highlighted by 26% year-over-year growth in Fanapt sales, the groundbreaking U.S. launch... Full story

Yahoo Finance • 23 days ago

Model N Appoints Thomas Gibbs to Board of Directors

Seasoned pharmaceutical executive brings over 25 years of commercial leadership to Model N board REDWOOD CITY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Model N, a leading end-to-end commercialization, revenue optimization, and compliance... Full story

Yahoo Finance • 24 days ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks declined Monday afternoon, with the NYSE Health Care Index and the State Street H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer

Geron Corporation (NASDAQ:GERN) is one of the best growth stocks under $10 to invest in. On April 13, Geron Corporation appointed Timothy Williams as Executive Vice President, Chief Legal Officer, and Corporate Secretary. A seasoned legal... Full story

Yahoo Finance • last month

Vanda Pharmaceuticals, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 20, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vanda Pharmaceuticals, Inc., (“Vanda" or the "Company") (NASDAQ: VNDA) investors that the firm has initiated an investigation into possible securities fraud, an... Full story

Yahoo Finance • 2 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index adding 0.1% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley

B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $17 from $14 and keeps a Buy rating on the shares. Following BYSANTI’s approval, the firm’s revenue model for Vanda has been updated, reflecting expected growth in... Full story

Yahoo Finance • 3 months ago

FDA Accepts Vanda's BLA For Imsidolimab In Generalized Pustular Psoriasis

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) on Wednesday said the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for imsidolimab for the treatment of Generalized Pustular Psoriasis (GPP), a r... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA).  Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 5 months ago

Stocks Decline as Chip Makers and Data Storage Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.33%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.35%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.34%.  March E-mini S&P futures (ESH26) are down -0.35%, and March E-mini N... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Nike, Corcept Therapeutics, Taiwan Semiconductor & more

Check out the companies making the biggest moves midday: Nike — Shares of the sneaker giant rose around 4% after board members Tim Cook and Robert Holmes Swan, as well as Nike CEO Elliott Hill, increased their stakes, Verity data shows. Th... Full story

Yahoo Finance • 5 months ago

Stocks Slide on Weakness in Megacap Tech Stocks

The S&P 500 Index ($SPX) (SPY) today is down -0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.18%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.19%.  March E-mini S&P futures (ESH26) are down -0.17%, and March E-mini N... Full story

Yahoo Finance • 5 months ago

Vanda Jumps 21% After FDA Approves Motion Sickness Therapy

This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S. Food and Drug Administration approved its motion sickness therapy Nereus, also known as tradipitant, a dr... Full story

Yahoo Finance • 5 months ago

Biggest stock movers Wednesday: Vanda Pharmaceuticals and Cybin

[Market Movers Stock Market Ticker Words 3d Illustration] iQoncept U.S. stock futures edged lower on Wednesday, the final trading day of 2025, extending a three-session losing streak for major U.S. benchmarks. Here are some of Wednesday'... Full story

Yahoo Finance • 5 months ago

Trending tickers: Nvidia, Caterpillar, Vanda Pharmaceuticals and Walker Crips

Nvidia (NVDA) Shares in Nvidia fell in pre-market trading on Wednesday despite reports that the chipmaker is scrambling to meet strong demand from Chinese technology groups for its H200 AI chips and has approached TSMC (TSM) to ramp up pr... Full story

Yahoo Finance • 5 months ago

3 Biotech Stocks With Major 2026 Catalysts

The biotech sector staged a robust comeback in 2025, with the Nasdaq Biotechnology Index climbing 33.8%. Although concerns about potential high tariffs initially hurt the industry, sentiment among investors rebounded sharply, powering a no... Full story

Yahoo Finance • 6 months ago

Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed

(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments. Sensei Biotherapeutics Inc. (SNSE) soared 62.9% to $17.20... Full story